Regard Raises $61M in Series B to Enhance AI-Powered Clinical Insights Platform
Regard is focused on bridging the clinical insights gap in healthcare through advanced AI technology.
Company Name: Regard
Location: Los Angeles, CA, USA
Sector: Healthcare Technology, Artificial Intelligence
Funding Details: Raised $61M in Series B funding. The round was led by Oak HC/FT, with participation from Cedars-Sinai Health Ventures and existing investors TenOneTen Ventures, Calibrate Ventures, and Techstars.
Purpose of Investment: To accelerate product development with their core clinical insights platform, invest in fundamental research in large language models (LLMs), and expand service offerings beyond inpatient facilities.
Leadership: Led by CEO Eli Ben-Joseph.
Product: Regard offers an AI-powered clinical insights platform that enhances the quality of patient care by analyzing comprehensive patient data to recommend diagnoses. This platform helps clinicians by providing critical insights, ensuring accurate and complete documentation in standardized formats, thereby improving the efficiency and effectiveness of healthcare delivery.
About Company: Regard is focused on bridging the clinical insights gap in healthcare through advanced AI technology. The platform supports clinicians by delivering actionable and precise insights derived from extensive patient data, facilitating better decision-making and care provision. With this latest funding, Regard is set to further develop its technology, expand its reach beyond inpatient settings, and continue contributing to transformative changes in the healthcare industry.
